Dr Reddys Laboratories Share Price Today - Live Blog for June 09, 2025

Dr Reddys Laboratories Ltd's share price has fallen by -0.03%, a situation worth noting. At present, the stock is trading at ₹1,319.50. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.4900, while the industry PE ratio is 34.1655.

Dr Reddys Laboratories Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,318.65. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,319.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd remained fixed, with no fluctuations, and is currently at ₹1,321.80. Investors may choose to investigate the factors contributing to this price stability and whether it presents an investment opportunity.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.05% gain, with the share price now at ₹1,321.80. Notably, the stock's PE ratio stands at 19.4900, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd witnessed a substantial 0.08% increase in its share price and is currently trading at ₹1,322.20. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's share price has dropped by -0.01%, a development that warrants careful analysis. Presently trading at ₹1,321.20, investors are assessing whether this presents an opportunity or a risk.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,319.55. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.4900, while the industry PE is 34.1655.

The share price of Dr Reddys Laboratories Ltd experienced a -0.01% slump and is currently trading at ₹1,320.90. While the stock maintains a PE ratio of 19.4900, the industry PE is 34.1655, raising questions about valuation.

Dr Reddys Laboratories Ltd share price surged by 0.14%. With its current market price standing at ₹1,321.00 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's share price has dropped by -0.33%, a development that warrants careful analysis. Presently trading at ₹1,318.20, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd witnessed a -0.33% drop in its share price and is currently trading at ₹1,318.20. With the stock's PE at 19.4900 and the industry PE at 34.1655, investors are weighing their options.

Dr Reddys Laboratories Ltd witnessed a -0.33% decrease in its share price, and it is currently trading at ₹1,318.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a -0.33% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,318.20. Investors should examine the factors driving this decline. The stock's PE ratio is 19.4900, whereas the industry PE ratio stands at 34.1655.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.11%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,323.15 per share.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.20% gain, with the share price now at ₹1,321.65. Notably, the stock's PE ratio stands at 19.4900, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd observed a remarkable 0.09% surge in its share price and is presently trading at ₹1,319.20. The increased investor interest is driving this surge.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.25%, reaching the current market price of ₹1,317.60. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.08%. At this moment, it's actively trading at ₹1,314.35, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd experienced a -0.14% downturn in its share price, and it's currently trading at ₹1,313.10. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,315.20. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.4900, while the industry PE is 34.1655.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.11% upswing, and it's currently trading at ₹1,315.50 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.11%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,315.50 per share.

Dr Reddys Laboratories Ltd's share price has fallen by -0.24%, a situation worth noting. At present, the stock is trading at ₹1,314.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.4900, while the industry PE ratio is 34.1655.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.05% uptick in its share price. As a result, it's now actively trading at ₹1,317.10 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.13% uptick, and they are currently valued at ₹1,316.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.56%, reaching a current market price of ₹1,313.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Demonstrating a commendable 0.14% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,322.75. In terms of valuation, the stock maintains a PE ratio of 19.4900, while the industry PE ratio stands at 34.1655.